Global Bone Tumor Ablation Devices Market to surpass US$ 111.1 million by 2027, Says Coherent Market Insights (CMI)

·4 min read

According to Coherent Market Insights, the global bone tumor ablation devices market is estimated to be valued at US$ 56.2 million in 2020 and is expected to exhibit a CAGR of 10.2% during the forecast period (2020-2027).

Key Trends and Analysis of the Global Bone Tumor Ablation Devices Market:

Successful and multiple use of the microwave ablation technique for the treatment of various diseases is expected to increase the sales of bone tumor ablation devices worldwide, thereby strengthening the position of the companies in the global market. For instance, according to the doctors at National Taiwan University are successfully using microwave energy to minimally invasively treat tumors in the lung with higher local success rate of 84% compared to historical 67-78% reported, as of December 2019.

Major companies in the Europe region are involved in various growth strategies such collaboration, acquisition for research and development of new technology, in order to enhance their market presence. For instance, Medtronic plc acquired OsteoCool device technology from Baylis Medical in 2015.

Various key players in the market are entering the market through inorganic growth strategies such as mergers and acquisitions. For instance, in August 2020, Olympus Corporation announced signing of a definitive agreement to acquire Arc Medical Design Limited, a subsidiary of Norgine B.V. Under the agreement, Olympus will acquire Arc Medical Design and obtain full rights of its medical products. Post-acquisition, Olympus Corporation is planning to design, manufacture, and distribute the products worldwide.

Furthermore, rising adoption of ablation devices by the surgeons for treatment in different therapeutic categories is expected to drive growth of the market in the Middle East. For instance, in 2019, IceCure Medical, an Israel-based company, received Israeli AMAR authorization (an Israeli Ministry of Health’s medical device regulation unit) to use its freezing technology in treatment of benign and malignant tumors of bones, liver, lymphatic tissue, lymph nodes, and endocrine glands.

Request Sample Copy of this Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/4319

Key Market Takeaways:

The global bone tumor ablation devices market is expected to exhibit a CAGR of 10.2% during the forecast period (2020-2027), owing to the rising prevalence of bone cancer, or rare bone disorders worldwide. For instance, according to the National Organization for Rare Disorders, Ewing sarcoma affects males more often than females. It may affect individuals of any age, but most often occurs in individuals between 10 and 20 years of age. The annual incidence of Ewing sarcoma is 2.93 children per 1,000,000 in the U.S. Around 200-250 children and adolescents in the U.S. are diagnosed with a tumor in the Ewing family of tumors, each year.

Competitive Landscape:

Key players in the North America bone tumor ablation devices market are focused on development of various bone tumor ablation devices, which is expected to drive growth of the market during the forecast period. For instance, in December 2015, DFINE, Inc., announced the commercial launch of its Long SpineSTAR Ablation Instrument. Long SpineSTAR is the latest innovation by the Silicon Valley medical device manufacturer and is part of the company’s flagship STAR Tumor Ablation System.

Key players operating in the global bone tumor ablation devices market include Medtronic Plc., Merit Medical Systems Inc., MedWaves Inc., AngioDynamics Inc., Olympus Corporation, Varian Medical Systems, Inc., Mermaid Medical A/S, RF Medical Co., Ltd., and Misomix Inc.

Buy-Now this Research Report for detailed market insights: https://www.coherentmarketinsights.com/insight/buy-now/4319

Bone Tumor Ablation Devices Market Segmentation:

  • By Technology:

    • Radiofrequency Ablation

    • Microwave Ablation

    • Cryoablation

    • Others

  • By Indication:

    • Osteosarcoma

    • Chondrosarcoma

    • Ewing’s Sarcoma

    • Metastatic Bone Cancer Bone Cancer Bone Cancer

    • Others

  • By End User:

    • Hospitals

    • Ambulatory Surgical Centers

    • Specialty Clinics

  • By Region:

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

      • Italy

      • Spain

      • France

      • Russia

      • Rest of Europe

    • Asia Pacific

      • Australia

      • India

      • China

      • Japan

      • ASEAN

      • South Korea

      • Rest of Asia Pacific

    • Latin America

      • Brazil

      • Mexico

      • Argentina

      • Rest of Latin America

    • Middle East

      • GCC

      • Israel

      • Rest of Middle East

    • Africa

      • South Africa

      • Central Africa

      • North Africa

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. Our client base includes players from across various business verticals in over 57 countries worldwide.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210305005188/en/

Contacts

Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
Phone:
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com
Follow Us: LinkedIn | Twitter